Device Trial Radar · NCT07287111
Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
797
Actual
Start
Aug 30, 2025
Primary completion
Oct 7, 2025
Study completion Jul 28, 2026
Sponsor
- Lead sponsor
- BeamWorks Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 17, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a retrospective, fully-crossed, multi-reader, multi-case (MRMC) study to evaluate the effectiveness of 'CadAI-B Dx' (CadAI-B) for decision support in breast ultrasound. The study compares the diagnostic performance of readers interpreting breast ultrasound images with and without the aid of CadAI-B. A total of 797 patient cases will be included, comprising 350 cases with a confirmed diagnosis of malignancy and 447 cases with a confirmed benign diagnosis. Sixteen readers will participate in the study to evaluate the device.
Conditions
- Breast Cancer
- Breast Neoplasms
Interventions
CadAI-B DxDevice
CadAI-B Dx is a Software as a Medical Device (SaMD) designed to assist physicians by providing Computer-Aided Detection (CADe) and Diagnosis (CADx) capabilities in breast ultrasound interpretation. The software automatically processes the image to identify suspicious regions (Lesion Detection) and provides a quantitative malignancy score (CadAI-Score) mapped to a corresponding BI-RADS Category. It also analyzes lesion size and BI-RADS lexicon descriptors.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Localization Receiver Operating Characteristic (LROC) Curve (AULROC)Time frame: Through study completion, approximately 2 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yonsei University Severance Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.